PremiumCompany AnnouncementsAstraZeneca Extends COPD Bet With New Long‑Term Tozorakimab Safety Study3h agoAZN
PremiumCompany AnnouncementsAstraZeneca Advances First-in-Human AZD8359 Study in Metastatic Prostate Cancer3h agoAZN